Literature DB >> 6526796

Different therapeutic regimens in irritable bowel syndrome.

P Nigam, K K Kapoor, C K Rastog, A Kumar, A K Gupta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6526796

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN： 0004-5772


× No keyword cloud information.
  12 in total

Review 1.  Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment.

Authors:  P Paré; Ronald Bridges; Malcolm C Champion; Subhas C Ganguli; James R Gray; E Jan Irvine; Victor Plourde; Pierre Poitras; Geoffrey K Turnbull; Paul Moayyedi; Nigel Flook; Stephen M Collins
Journal:  Can J Gastroenterol       Date:  2007-04       Impact factor: 3.522

2.  Optimum dosage of ispaghula husk in patients with irritable bowel syndrome: correlation of symptom relief with whole gut transit time and stool weight.

Authors:  A Kumar; N Kumar; J C Vij; S K Sarin; B S Anand
Journal:  Gut       Date:  1987-02       Impact factor: 23.059

3.  Hyoscine butylbromide versus acetaminophen for nonspecific colicky abdominal pain in children: a randomized controlled trial.

Authors:  Naveen Poonai; Kriti Kumar; Kamary Coriolano; Graham Thompson; Shaily Brahmbhatt; Emily Dzongowski; Holly Stevens; Priti Gupta; Michael Miller; Sharlene Elsie; Dhandapani Ashok; Gary Joubert; Rod Lim; Andreana Bütter; Samina Ali
Journal:  CMAJ       Date:  2020-11-30       Impact factor: 8.262

4.  Evidence-based clinical practice guidelines for irritable bowel syndrome.

Authors:  Shin Fukudo; Hiroshi Kaneko; Hirotada Akiho; Masahiko Inamori; Yuka Endo; Toshikatsu Okumura; Motoyori Kanazawa; Takeshi Kamiya; Ken Sato; Toshimi Chiba; Kenji Furuta; Shigeru Yamato; Tetsuo Arakawa; Yoshihide Fujiyama; Takeshi Azuma; Kazuma Fujimoto; Tetsuya Mine; Soichiro Miura; Yoshikazu Kinoshita; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2014-12-12       Impact factor: 7.527

Review 5.  Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain.

Authors:  Guido N Tytgat
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 6.  Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.

Authors:  Lisa Ruepert; A Otto Quartero; Niek J de Wit; Geert J van der Heijden; Gregory Rubin; Jean Wm Muris
Journal:  Cochrane Database Syst Rev       Date:  2011-08-10

Review 7.  Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition.

Authors:  Kyung Ho Song; Hye-Kyung Jung; Hyun Jin Kim; Hoon Sup Koo; Yong Hwan Kwon; Hyun Duk Shin; Hyun Chul Lim; Jeong Eun Shin; Sung Eun Kim; Dae Hyeon Cho; Jeong Hwan Kim; Hyun Jung Kim
Journal:  J Neurogastroenterol Motil       Date:  2018-04-30       Impact factor: 4.924

Review 8.  Second Asian Consensus on Irritable Bowel Syndrome.

Authors:  Kok Ann Gwee; Sutep Gonlachanvit; Uday C Ghoshal; Andrew S B Chua; Hiroto Miwa; Justin Wu; Young-Tae Bak; Oh Young Lee; Ching-Liang Lu; Hyojin Park; Minhu Chen; Ari F Syam; Philip Abraham; Jose Sollano; Chi-Sen Chang; Hidekazu Suzuki; Xiucai Fang; Shin Fukudo; Myung-Gyu Choi; Xiaohua Hou; Michio Hongo
Journal:  J Neurogastroenterol Motil       Date:  2019-07-01       Impact factor: 4.924

9.  Efficacy and Safety of a Novel Herbal Medicine in the Treatment of Irritable Bowel Syndrome: A Randomized Double-Blinded Clinical Trial.

Authors:  Ghasem Bordbar; Mohammad Bagher Miri; Mahmoud Omidi; Saeed Shoja; Malihe Akhavan
Journal:  Gastroenterol Res Pract       Date:  2020-05-27       Impact factor: 2.260

Review 10.  Shortcomings of Trials Assessing Antidepressants in the Management of Irritable Bowel Syndrome: A Critical Review.

Authors:  Sun Jung Oh; Will Takakura; Ali Rezaie
Journal:  J Clin Med       Date:  2020-09-11       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.